247 related articles for article (PubMed ID: 36897749)
21. [Mechanism of Jiming Powder in ameliorating heart failure with preserved ejection fraction based on metabolomics].
Wei XQ; Fan XY; Pu HY; Li S; Tang JY; Gao K; Li FH; Yu X; Guo SZ
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(17):4747-4760. PubMed ID: 37802814
[TBL] [Abstract][Full Text] [Related]
22. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
23. Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Wu H; Tang LX; Wang XM; Li LP; Chen XK; He YJ; Yang DZ; Shi Y; Shou JL; Zhang ZS; Wang L; Lu BJ; An SM; Zeng CY; Wang WE
Acta Pharmacol Sin; 2023 Jun; 44(6):1149-1160. PubMed ID: 36473990
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1β Disruption Protects Male Mice From Heart Failure With Preserved Ejection Fraction Pathogenesis.
Srinivas BK; Bourdi A; O'Regan JD; Malavalli KD; Rhaleb NE; Belmadani S; Matrougui K
J Am Heart Assoc; 2023 Jul; 12(14):e029668. PubMed ID: 37345828
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
[TBL] [Abstract][Full Text] [Related]
26. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
[TBL] [Abstract][Full Text] [Related]
27. Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction.
Saiki H; Moulay G; Guenzel AJ; Liu W; Decklever TD; Classic KL; Pham L; Chen HH; Burnett JC; Russell SJ; Redfield MM
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H392-H407. PubMed ID: 28550173
[TBL] [Abstract][Full Text] [Related]
28. Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathways.
Dawuti A; Sun S; Wang R; Gong D; Liu R; Kong D; Yuan T; Zhou J; Lu Y; Wang S; Du G; Fang L
Biomed Pharmacother; 2023 Dec; 168():115837. PubMed ID: 37931518
[TBL] [Abstract][Full Text] [Related]
29. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
Van Aelst LNL; Arrigo M; Placido R; Akiyama E; Girerd N; Zannad F; Manivet P; Rossignol P; Badoz M; Sadoune M; Launay JM; Gayat E; Lam CSP; Cohen-Solal A; Mebazaa A; Seronde MF
Eur J Heart Fail; 2018 Apr; 20(4):738-747. PubMed ID: 29251818
[TBL] [Abstract][Full Text] [Related]
30. Dapagliflozin Attenuates Heart Failure With Preserved Ejection Fraction Remodeling and Dysfunction by Elevating β-Hydroxybutyrate-activated Citrate Synthase.
Zhang X; Wang N; Fu P; An Y; Sun F; Wang C; Han X; Zhang Y; Yu X; Liu Y
J Cardiovasc Pharmacol; 2023 Nov; 82(5):375-388. PubMed ID: 37643027
[TBL] [Abstract][Full Text] [Related]
31. Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.
Valero-Muñoz M; Li S; Wilson RM; Hulsmans M; Aprahamian T; Fuster JJ; Nahrendorf M; Scherer PE; Sam F
Circ Heart Fail; 2016 Jan; 9(1):e002724. PubMed ID: 26721917
[TBL] [Abstract][Full Text] [Related]
32. Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study.
Eidizadeh A; Schnelle M; Leha A; Edelmann F; Nolte K; Werhahn SM; Binder L; Wachter R
ESC Heart Fail; 2023 Feb; 10(1):200-210. PubMed ID: 36184749
[TBL] [Abstract][Full Text] [Related]
33. Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.
Cochran JD; Yura Y; Thel MC; Doviak H; Polizio AH; Arai Y; Arai Y; Horitani K; Park E; Chavkin NW; Kour A; Sano S; Mahajan N; Evans M; Huba M; Naya NM; Sun H; Ban YH; Hirschi KK; Toldo S; Abbate A; Druley TE; Ruberg FL; Maurer MS; Ezekowitz JA; Dyck JRB; Walsh K
Circulation; 2023 Oct; 148(15):1165-1178. PubMed ID: 37681311
[TBL] [Abstract][Full Text] [Related]
34. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
[TBL] [Abstract][Full Text] [Related]
35. Cell therapy attenuates endothelial dysfunction in hypertensive rats with heart failure and preserved ejection fraction.
de Couto G; Mesquita T; Wu X; Rajewski A; Huang F; Akhmerov A; Na N; Wu D; Wang Y; Li L; Tran M; Kilfoil P; Cingolani E; Marbán E
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H892-H903. PubMed ID: 36083797
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of Na
Primessnig U; Bracic T; Levijoki J; Otsomaa L; Pollesello P; Falcke M; Pieske B; Heinzel FR
Eur J Heart Fail; 2019 Dec; 21(12):1543-1552. PubMed ID: 31762174
[TBL] [Abstract][Full Text] [Related]
37. Preload dependence in an animal model of mild heart failure with preserved ejection fraction (HFpEF).
Jacobsen JCB; Schubert IH; Larsen K; Terzic D; Thisted L; Thomsen MB
Acta Physiol (Oxf); 2024 Mar; 240(3):e14099. PubMed ID: 38230889
[TBL] [Abstract][Full Text] [Related]
38. Chronic high-rate pacing induces heart failure with preserved ejection fraction-like phenotype in Ossabaw swine.
Tune JD; Goodwill AG; Baker HE; Dick GM; Warne CM; Tucker SM; Essajee SI; Bailey CA; Klasing JA; Russell JJ; McCallinhart PE; Trask AJ; Bender SB
Basic Res Cardiol; 2022 Oct; 117(1):50. PubMed ID: 36222894
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.
Lindman BR; Dávila-Román VG; Mann DL; McNulty S; Semigran MJ; Lewis GD; de las Fuentes L; Joseph SM; Vader J; Hernandez AF; Redfield MM
J Am Coll Cardiol; 2014 Aug; 64(6):541-9. PubMed ID: 25104521
[TBL] [Abstract][Full Text] [Related]
40. The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
Obokata M; Kane GC; Reddy YNV; Melenovsky V; Olson TP; Jarolim P; Borlaug BA
Eur Heart J; 2019 Dec; 40(45):3707-3717. PubMed ID: 31513270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]